Off-Label Corticosteroid Use Could Get Contraindication From FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Limited evidence on risks – and benefits – for epidural corticosteroid injections among challenges that FDA’s Anesthetic and Analgesic Drugs Products Advisory Committee faces.